Page last updated: 2024-12-07

chlorodiethylenetriamine platinum

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Chlorodiethylenetriamine platinum (also known as CHIP) is a platinum-based anticancer drug that has shown promising activity against various types of cancer, particularly ovarian cancer. It is synthesized through a multi-step process involving the reaction of potassium tetrachloroplatinate(II) with diethylenetriamine. CHIP exerts its anticancer effects by binding to DNA, inhibiting its replication and transcription, ultimately leading to cell death. The compound is particularly effective in targeting tumors that have developed resistance to conventional platinum-based drugs like cisplatin. Research on CHIP focuses on understanding its mechanism of action, optimizing its delivery methods, and exploring its potential use in combination therapies. The compound's ability to overcome drug resistance and its relatively low toxicity profile make it a promising candidate for future cancer treatments.'

chlorodiethylenetriamine platinum: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID107836
MeSH IDM0102052

Synonyms (12)

Synonym
chloro(diethylenetriammine)platinum(ii) chloride
chloro(diethylenetriamine)platinum(ii) chloride
diethylenetriamminechloroplatinum chloride
diethylenetriaminechloroplatinum(ii) chloride
platinum(1+), chloro(diethylenetriamine)-, chloride
monodentate chloro(diethylenetriamine)platinum(ii) chloride
platinum(1+), (n-(2-(amino-kappan)ethyl)-1,2-ethanediamine-kappan,kappan')chloro-, chloride, (sp-4-2)-
chlorodiethylenetriamine platinum
platinum(1+), (n-(2-aminoethyl)-1,2-ethanediamine-n,n')chloro-, chloride, (sp-4-2)-
chlorodiethylenetriamineplatinum(ii)chloride
14215-58-8
bis(2-azanidylethyl)azanide;platinum(4+);chloride
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (29)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (48.28)18.7374
1990's10 (34.48)18.2507
2000's4 (13.79)29.6817
2010's1 (3.45)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.66 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index4.09 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.66)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other30 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]